• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 62
  • 39
  • 13
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • Tagged with
  • 144
  • 89
  • 46
  • 33
  • 23
  • 17
  • 17
  • 15
  • 15
  • 14
  • 13
  • 13
  • 13
  • 11
  • 10
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
141

Aplicação do método de linearização de Lyapunov na análise de uma dinâmica não linear para controle populacional do mosquito Aedes aegypti / Application of the Lyapunov linearization method in the analysis of a nonlinear dynamics for mosquito control population Aedes aegypti

Maranho, Luiz Cesar 20 August 2018 (has links)
Submitted by Luiz Cesar Maranho (lc-maranho@bol.com.br) on 2018-10-11T20:16:50Z No. of bitstreams: 1 Dissertação Final.pdf: 1883342 bytes, checksum: 85a25606a3113b39d6d4354dcaa161d8 (MD5) / Approved for entry into archive by Elza Mitiko Sato null (elzasato@ibilce.unesp.br) on 2018-10-15T12:39:20Z (GMT) No. of bitstreams: 1 maranho_lc_me_sjrp.pdf: 5069791 bytes, checksum: 2501e6acc67bdd7103eb807f326a4c0b (MD5) / Made available in DSpace on 2018-10-15T12:39:20Z (GMT). No. of bitstreams: 1 maranho_lc_me_sjrp.pdf: 5069791 bytes, checksum: 2501e6acc67bdd7103eb807f326a4c0b (MD5) Previous issue date: 2018-08-20 / O mosquito Aedes aegypti é o principal vetor responsável por diversas arboviroses como a dengue, a febre amarela, o vírus zika e a febre chikungunya. Devido a sua resistência, adaptabilidade e proximidade ao homem, o Aedes aegypti é atualmente um dos maiores problemas de saúde pública no Brasil e nas Américas. Mesmo com os avanços e investimentos em pesquisas com vacinas, monitoramento, campanhas educativas e diversos tipos de controle deste vetor, ainda não existe um método eficaz para controlar e erradicar o mosquito. Portanto, esse trabalho destina-se ao auxílio na criação de estratégias para controlar esse agente transmissor, mediante a análise do espaço de estados e a estabilidade assintótica de uma dinâmica não linear para controle populacional do Aedes aegypti via a técnica de linearização de Lyapunov, além de apresentação de formas de prevenção e combate aos criadouros do mosquito. A dinâmica não linear proposta é uma dinâmica simplificada obtida de um modelo não linear existente na literatura, proposto por Esteva e Yang em 2005 e se baseia no ciclo de vida do mosquito, que é dividido em duas fases: fase imatura ou aquática (ovos, larvas e pupas) e fase alada (mosquitos adultos). Na fase adulta, os mosquitos são divididos em machos, fêmeas imaturas e fêmeas fertilizadas, sendo que a dinâmica proposta nesta dissertação de mestrado é baseada nos estudos efetuados por Reis desde 2016, obtendo um modelo simplificado no qual a soma das densidades das populações de fêmeas imaturas e fêmeas fertilizadas serão consideradas como fêmeas adultas. / The mosquito Aedes aegypti is the main vector responsible for several arboviruses such as dengue fever, yellow fever, zika virus and chikungunya fever. Due to its resistance, adaptability and proximity to humans, Aedes aegypti is currently one of the major public health problems in Brazil and the Americas. Even with the advances and investments in research with vaccines, monitoring, educational campaigns and various types of control of this vector, there is still no effective method to control and eradicate the mosquito. Therefore, this work is intended to aid in the creation of strategies to control this transmitting agent by analyzing the state space and the asymptotic stability of a nonlinear dynamics for population control of Aedes aegypti via the Lyapunov linearization technique to present ways of preventing and combating mosquito breeding sites. The proposed nonlinear dynamics is a simplified dynamics obtained from a nonlinear model existing in the literature, proposed by Esteva and Yang in 2005 and based on the life cycle of the mosquito, which is divided into two phases: immature or aquatic phase (eggs, larvae and pupae) and winged phase (adult mosquitoes). In the adult phase, mosquitoes are divided into males, immature females and fertilized females, and the dynamics proposed in this dissertation is based on studies carried out by Reis since 2016, obtaining a simplified model in which the sum of the densities of the populations of females immature and fertilized females will be considered as adult females.
142

Safety and Stability of Samples Stored on Filter Paper for Molecular Arbovirus Diagnosis

Bringeland, Emelie January 2021 (has links)
Expanding urbanization, climate change, and population growth contribute to increased transmission and spread of arthropod-borne viruses (arboviruses), many of which cause severe disease in humans. Pathogenic arboviruses include dengue, Zika, tick-borne encephalitis, and sindbis viruses, which together threaten more than half the global population. Thus, there is a constant need for safe, specific, and sensitive molecular tests to identify early-stage infections for accurate diagnosis and molecular epidemiological data for disease prevention and control. The study tested the biosafety of using FTA™ cards when working with pathogenic arboviruses by conducting an infectivity assay using sindbis virus. Conditions for RNA extraction and storage of arboviruses on FTA were analyzed by measuring viral RNA (vRNA) stability using a SYBR-Green, Pan-Flavi RT-qPCR method composed of degenerate primers able to detect a variety of flaviviruses. Data from a Pan-Flavi RT-qPCR study comprising of 222 clinical blood and serum samples collected from a 2018 dengue virus outbreak in Hanoi (Vietnam) was analyzed to establish applicability of FTA for molecular epidemiology and diagnosis. Results showed that sindbis virus infectivity was inhibited by FTA-adsorption. FTA-adsorbed arboviruses were extracted with the highest yield using Trizol extraction and were preserved at storage at 4-20ºC for up to 30 days. The results showed that clinical blood samples acquired higher yields of vRNA for molecular testing than serum samples and that it may be possible to perform sequencing for genomic analysis. The study suggests that FTA cards may facilitate the storage and transportation of adsorbed arboviruses for downstream molecular epidemiological and diagnostic tests.
143

Robust Drug Design Strategies and Discovery Targeting Viral Proteases

Zephyr, Jacqueto 20 August 2021 (has links)
Viral proteases play crucial roles in the life cycle and maturation of many viruses by processing the viral polyprotein after translation and in some cases cleaving host proteins associated with the immune response. The essential role of viral proteases makes them attractive therapeutic targets. In this thesis, I provide an introductory summary of viral proteases, their structure, mechanism, and inhibition, while the breadth of this thesis focuses on the Hepatitis C virus (HCV) NS3/4A and Zika virus (ZIKV) NS2B/NS3 viral proteases. HCV NS3/4A protease inhibitors (PIs) have become a mainstay in combination therapies. However, drug resistance remains a major problem against these PIs. In this thesis, I applied insights from the HCV substrate envelope (SE) model to develop strategies for designing PIs that are less susceptible to resistance. Also, I used the HCV NS3/4A protease as a model system to decipher the molecular mechanism and role of fluorination in HCV PIs potency and drug resistance. The drug design strategies described in this thesis have broad applications in drug design. The ZIKV is an emerging global threat, and currently, with no treatment available. In this thesis, I described the discovery, biochemical and antiviral evaluation of novel noncompetitive quinoxaline-based inhibitors of the ZIKV NS2B/NS3 protease. The inhibitors are proposed to interfere with NS2 binding to NS3, thereby preventing the protease from adopting the closed and active conformation. The inhibitors from this work will serve as lead compounds for further inhibitor development toward the goal of developing antivirals.
144

Role of the 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) in hepatitis C and related flaviviruses replication.

Mohamed, Bassim 08 1900 (has links)
Dans le monde entier, les infections virales causent des problèmes de santé majeurs et récurrents, engendrant de sérieux problèmes socio-économiques. Notamment, les virus de la famille Flaviviridae qui représentent un fardeau considérable sur la santé mondiale et font partie des domaines prioritaires de la virologie médicale selon le rapport 2016 du ‘Global Virus Network’. Bien que le traitement actuel contre le virus de l’hépatite C (VHC) ait un taux de guérison dépassant 98%, d’autres comme le virus de la dengue (DENV) et le virus zika (ZIKV) n’ont pas encore de traitement spécifique autorisé. En prenant avantage de la grande expertise de notre laboratoire dans l’étude du VHC, nous avons utilisé des données d’une étude de biologie des systèmes visant à identifier l’interactome des différentes protéines virales. Les techniques utilisées ont combiné l’immunoprécipitation des protéines virales suivie de l’identification des protéines interacteurs humaines par spectrométrie de masse. Des études de génomique fonctionnelle par ARN interférent (ARNi) ont permis d’étudier l’effet de la diminution de l’expression des protéines identifiées sur la réplication du VHC. Cette étude a conduit à la découverte de l’interactant spécifique 17-bêta-hydroxystéroïde déshydrogénase de type 12 (HSD17B12 ou DHB12) de la protéine virale Core comme facteur cellulaire requis à la réplication du VHC. HSD17B12 est une enzyme cellulaire dont l’activité catalytique est requise pour l’élongation des acides gras à très longue chaîne (VLCFA) lors de la deuxième des quatre réactions du cycle d’élongation. Dans cette étude, nous avons déterminé que les cycles de réplication du VHC, ZIKV et DENV dépendent de l’expression et de l’activité métabolique du facteur cellulaire HSD17B12. Ainsi, nous avons étudié les effets de l’inhibition de l’expression génique par ARNi et de façon pharmacologique sur la réplication de plusieurs flavivirus dans une approche antivirale à large spectre. Nous avons démontré que le silençage de HSD17B12 diminue significativement la réplication virale, l’expression des protéines virales et la production de particules infectieuses de cellules Huh7.5 infectées par la souche JFH1 du VHC. L'analyse de la localisation cellulaire de HSD17B12 dans des ii cellules infectées suggère une colocalisation avec l'ARN double brin (ARNdb) aux sites de réplication virale, ainsi qu’avec la protéine Core (et les gouttelettes lipidiques) aux des sites d’assemblage du virus. Nous avons également observé que le silençage de HSD17B12 réduit considérablement le nombre et la taille des gouttelettes lipidiques. En accord avec ces données, la diminution de l’expression de HSD17B12 par ARNi réduit significativement l’acide oléique et les espèces lipidiques telles que triglycérides et phosphatidyl-éthanolamine dans l'extrait cellulaire total. Ces travaux suggèrent une contribution de la capacité métabolique de HSD17B12 lors de la réplication du VHC. De même, nous avons démontré que le silençage de HSD17B12 réduit significativement les particules infectieuses de cellules infectées par DENV et ZIKV. Ces études supportent le rôle de HSD17B12 dans l’efficacité des processus de la réplication de l'ARN viral et de l’assemblage de particules virales. De plus, l'inhibiteur spécifique de HSD17B12, INH-12, réduit la réplication du VHC à des concentrations pour lesquelles aucune cytotoxicité notable n'est observée. Le traitement avec 20 μM d'INH-12 réduit jusqu'à 1,000 fois les particules infectieuses produite par des cellules Huh-7.5 infectées par DENV et ZIKV lors de plusieurs cycles de réplication, et bloque complètement l'expression des protéines virales. En conclusion, ces travaux ont conduit à une meilleure compréhension du rôle de HSD17B12 lors de la synthèse de VLCFA et de lipides requise à la réplication du VHC, permettant d’explorer l’inhibition de HSD17B12 et de l’élongation d’acides gras à très longue chaîne comme nouvelle approche thérapeutique pour le traitement à large spectre des infections par les virus de la famille Flaviviridae. / Infections with viruses are major recurrent socio-economical and health problems worldwide. These include infections by viruses of the Flaviviridae family, which present a substantial global health burden and are among the priority areas of medical virology according to the Global Virus Network 2016 report. While the current treatment regimens for hepatitis C virus (HCV) infection have cure rates of more than 98%, other important members of Flaviviridae like dengue virus (DENV) and zika virus (ZIKV) have no specific licensed treatments. By taking advantage of the most-studied HCV, which our lab has developed a vast expertise in the last 20 years, we used proteomics data of an HCV interactome study, combining viral protein immunoprecipitation (IP) coupled to tandem mass spectrometry identification (IP-MS/MS) and functional genomics RNAi screening. The study uncovered the 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12, also named DHB12), as a specific host interactor of core that promotes HCV replication. HSD17B12 catalytic activity is involved in the synthesis of very-long-chain fatty acids (VLCFA) upon the second step of the elongation cycle. In this study, taking HCV as a virus model, we elucidated the dependency of HCV, dengue virus (DENV) and zika virus (ZIKV) replication on expression and metabolic capacity of the host factor HSD17B12. We investigated the effects of the inhibition of gene expression by RNAi and of its pharmacological enzymatic inhibition on flavivirus replication in a broad-spectrum antiviral approach. We showed that silencing expression of HSD17B12 decreases viral replication, viral proteins and iv infectious particle production of the JFH1 strain of HCV in Huh7.5 cells. The cellular localization analysis of HSD17B12 showed a co-staining with double-stranded RNA (dsRNA) at viral replication sites and with core protein (and lipid droplets) at virus assembly sites. Furthermore, HSD17B12 gene silencing drastically reduced the number and size of lipid droplets. In association, the reduced expression of HSD17B12 by RNAi decreases oleic acid levels and lipids such as triglycerides (TG) and phosphatidylethanolamine (PE) in whole-cell extract. The data suggested the requirement of the metabolic capacity of HSD17B12 for HCV replication. Similarly, we provide evidence that HSD17B12 silencing significantly reduces DENV and ZIKV infectious particles. The studies support a role of HSD17B12 for effective viral RNA replication and particle assembly processes. Moreover, the specific HSD17B12 inhibitor, INH-12, reduces HCV replication at concentrations for which no appreciable cytotoxicity is observed. The treatment of DENV- and ZIKV-infected Huh- 7.5 cells with 20 μM of INH-12 dramatically reduces production of infectious particles by up to 3-log10 in infection assays, and completely block viral protein expression. In conclusion, these studies extends our understanding of the role of HSD17B12 in VLCFA synthesis required for the replication of HCV, allowing to explore the inhibition of HSD17B12 and elongation of VLCFA as a novel therapeutic approach for the treatment of a broad-spectrum of viruses of the Flaviviridae family.

Page generated in 0.0435 seconds